(BNTX) – General News
-
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
-
Midday movers: Apple, Intel, United Airlines fall; Micron rises
-
BioNTech gets US agency notice over default on COVID vaccine royalties
-
Midday movers: Mobileye, Chipotle rise; Signet, BioNTech fall
-
Midday movers: Boeing, CrowdStrike and more
-
Pfizer, Tesla, Caterpillar, JetBlue fall premarket; Pinterest, Arista rise
-
Stock Market Today: Dow ends higher on tech gains as earnings season to heat up
-
S&P 500 jumps as big tech soaks up demand, shrugs off rising Treasury yields
-
COVID-19 vaccine stocks gain as Biden expected to request new vaccine, recommended for all
-
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
-
Arbutus files patent lawsuit against Pfizer/BioNTech over COVID vaccines
-
Midday movers: First Citizens BancShares, Novartis, Carnival Corp. and more
-
U.S. stocks were rising after deal for SVB eases worries about banks
-
Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents
-
FDA advisers recommend using same strain for initial COVID vaccine and boosters
-
Updated COVID boosters offer better protection than original -U.S. study
-
Pfizer COVID vaccine price hike to boost revenue for years, rivals may follow
-
U.S. authorizes updated COVID booster shots for children as young as 5
-
Pfizer/BioNTech seek FDA nod for new COVID boosters for children
-
CureVac files patent lawsuit in Germany against BioNTech over mRNA technology
-
Pfizer signs new $3.2 billion COVID vaccine deal with U.S. government
-
BioNTech to soon start mRNA vaccine factory construction in Rwanda
-
U.S. FDA authorizes Pfizer's COVID booster shot for young children
-
Pfizer to provide 10 million courses of COVID pill to developing countries -the Global Fund
-
N.Y. Won't Enforce Vaccine Booster Mandate For Health Workers - Bloomberg
-
U.S. Labor Dept withdrawing COVID vaccine rule for large employers
-
Fauci says 'prudent' to have Omicron vaccine, but may not be needed
-
Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine
-
U.S. Supreme Court blocks Biden vaccine-or-test policy for large businesses
-
BioNTech eyes up to 17 billion euros in vaccine revenue in 2022
-
Pfizer/BioNTech vaccine protects children against rare COVID-19 complication - CDC
-
CDC recommends Pfizer's COVID-19 booster for ages 12 to 15
-
U.S. CDC recommends five-month gap for Pfizer COVID-19 booster dose
-
Pfizer to provide 2.5 million additional doses of its COVID-19 pill to UK
-
'Tidal wave': Omicron could put U.S. COVID-19 surge into overdrive
-
Omicron more likely to reinfect than Delta, no milder - study
-
U.S. makes 16- and 17-year-olds eligible for COVID-19 boosters
-
Studies suggest Pfizer shot may protect only partially against Omicron
-
U.S. boosters surge to all-time high on Omicron fears
-
South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec
-
First known U.S. Omicron case found in fully vaccinated overseas traveler
-
EU brings forward Pfizer/BioNTech COVID shot for younger children to Dec 13
-
COVID-19 vaccine makers start work on Omicron-tailored shots
-
U.S. FDA considering lowering recommended age for Pfizer/BioNTech COVID-19 boosters
-
Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector
-
Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many
-
U.S. CDC backs COVID-19 boosters for high-risk adults, workers, older Americans
-
U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans
-
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
-
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine booster
Back to BNTX Stock Lookup